AI Terminal
Blencowe Resources PLC
Report Publication Announcement • Nov 5, 2020
5345_rns_2020-11-05_3170edc2-38a8-4126-afbb-38df75161259.html
Report Publication Announcement
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 2905E
Blencowe Resources PLC
05 November 2020
Date: 5 November 2020
Blencowe Resources Plc
("Blencowe" or the "Company")
Publication of New Research Note
Blencowe, the natural resources company focused on development of the Orom-Cross Graphite Project in Uganda, is pleased to advise that Align Research has today published an updated research note on the Company.
The research note provides an update on operations since the first research note issued in May 2020 and contains a new target price for Blencowe of 19.1p per share.
The research has been placed on the Company's website and can be found here:
https://blencoweresourcesplc.com/analyst-coverage/
For further information please contact:
| Blencowe Resources Plc Sam Quinn (London Director) |
www.blencoweresourcesplc.com Tel: +44 (0)1624 681 250 [email protected] |
| Brandon Hill Capital Limited Jonathan Evans (Corporate Finance) |
Tel: +44 (0)20 3463 5000 [email protected] |
Background
Orom-Cross is a potential world class graphite project both by size and end-product quality, with a high component of larger flakes identified from previous work performed. A 21-year Mining Licence was issued by the Ugandan Government in 2019 following extensive historical work on the deposit.
Orom-Cross presents as a large, shallow open pitable deposit, with an estimated resource in excess of 3 billion tonnes of graphite. Development of the resource is expected to benefit from a low strip ratio and free dig operations, thereby ensuring lower operating and capital costs.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCBIBFTMTJMBBM